Terms & Conditions
The overall goal is to deliver evidence-based insights across the healthcare system to redefine obesity and optimize future treatment.
The SOPHIA project (Stratification of Obesity Phenotypes to Optimise Future Obesity Therapy) is a Public-Private Partnership funded by the Innovative Medicines Initiative (IMI), in collaboration with the European Commission, and is part of a momentum shift in the study of obesity.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875534. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1D Exchange, JDRF, and Obesity Action Coalition. The project brings together healthcare professionals, academia, industry leaders, and patient organisations to change the future of obesity care.
This takes us one step closer to identifying the right treatment for the right patient at the right time. Using machine learning, federated health data, and a unique approach to shared value, the project is part of a momentum shift and new approach to obesity care and management worldwide.
